Harbor Capital Advisors Inc. acquired a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 22,005 shares of the company's stock, valued at approximately $1,277,000.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Global Retirement Partners LLC raised its stake in shares of Doximity by 468.1% in the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after buying an additional 440 shares during the period. Larson Financial Group LLC raised its stake in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after acquiring an additional 250 shares during the period. Optimum Investment Advisors purchased a new stake in Doximity during the fourth quarter valued at about $43,000. Kapitalo Investimentos Ltda bought a new position in Doximity during the fourth quarter worth about $50,000. Finally, Huntington National Bank boosted its position in Doximity by 1,440.8% during the fourth quarter. Huntington National Bank now owns 1,094 shares of the company's stock worth $58,000 after purchasing an additional 1,023 shares during the period. 87.19% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of analysts recently commented on the stock. Raymond James dropped their price target on shares of Doximity from $83.00 to $65.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Robert W. Baird dropped their target price on Doximity from $87.00 to $65.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Morgan Stanley reduced their price target on Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a research report on Thursday, April 24th. BTIG Research upgraded Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price objective on the stock in a research note on Monday, June 2nd. Finally, JPMorgan Chase & Co. dropped their price objective on Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a report on Tuesday, May 27th. Eleven equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $62.84.
Read Our Latest Stock Analysis on DOCS
Doximity Stock Down 1.8%
Shares of NASDAQ DOCS traded down $1.04 during mid-day trading on Friday, reaching $55.92. 1,284,854 shares of the company were exchanged, compared to its average volume of 2,136,392. Doximity, Inc. has a 52 week low of $25.00 and a 52 week high of $85.21. The company's 50 day moving average price is $55.02 and its 200 day moving average price is $58.41. The stock has a market capitalization of $10.50 billion, a PE ratio of 55.92, a PEG ratio of 4.10 and a beta of 1.32.
Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings data on Thursday, May 15th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. Doximity's quarterly revenue was up 17.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.25 EPS. On average, sell-side analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current year.
Insider Buying and Selling at Doximity
In related news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total value of $113,860.00. Following the transaction, the director now owns 16,618 shares in the company, valued at $946,062.74. This trade represents a 10.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Anna Bryson sold 45,000 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the completion of the sale, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at $20,440,552.95. This represents a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 51,000 shares of company stock worth $2,900,770 over the last ninety days. Insiders own 37.40% of the company's stock.
Doximity Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.